MedPath

Effects of Foot Muscle Strengthening in Daily Activity in Diabetic Neuropathic Patients

Not Applicable
Completed
Conditions
Diabetic Neuropathies
Interventions
Other: Intervention Group
Registration Number
NCT02790931
Lead Sponsor
University of Sao Paulo General Hospital
Brief Summary

The main objective of this trial is to investigate the effects of foot muscle strengthening in daily activity of patients with diabetic neuropathy.

Detailed Description

A randomized controlled trial will be performed with 77 patients with diabetic neuropathy. The participants will be randomly assigned into either a control group (recommended foot care by international consensus with no exercises) or an intervention group which will receive 12-week physical therapy exercises, twice a week, under the supervision of a physiotherapist, and twice a week being remotely supervised by a software at home. Every exercise has its own progression depending on the subjects' execution, increasing in intensity and difficulty.

The subjects will be evaluated in 5 different moments (Baseline, 6 weeks, 12 weeks, 24 weeks and 1 year follow-up)

The hypothesis of this study is that the intervention group will increase daily activity levels, increase self-selected and rapid walking speed, reduce the incidence of plantar ulcers, increase foot health and functionality, improve symptoms, increase tactile and vibration sensitivity, increased passive range of motion, improved quality of life, increased isometric strength of the feet and production of beneficial biomechanical changes during walking compared to the control group after 12 weeks of intervention and follow-up year.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
78
Inclusion Criteria
  • Diabetes mellitus type 1 or 2
  • Moderate or severe polyneuropathy confirmed with the fuzzy software
  • Ability to walk independently in the laboratory
  • Accessibility to electronic devices
  • Loss of at least 4 degrees of ankle range of motion
  • Loss of at least 1 degree of force in the clinical scale of the plantar interosseous or lumbrical muscles
Exclusion Criteria
  • Ulceration not healed for at least 6 months
  • Hallux amputation or total amputation of the foot
  • Receiving any physiotherapy intervention or offloading devices
  • Neurological or orthopedic impairments
  • Major vascular complications
  • Severe retinopathy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention GroupIntervention GroupPatients will receive a physical therapy intervention in groups twice/wk, and using a software twice/ wk for 3 months.
Primary Outcome Measures
NameTimeMethod
Daily Physical Activity12 weeks

Calculate the number of steps per week

Self Selected Gait Speed12 weeks

self selected gait speed shod walking velocity in a walkway

Fast Gait Speed12 weeks

Fast gait speed shod walking velocity in a walkway

Secondary Outcome Measures
NameTimeMethod
Foot and Ankle Kinematics During Gaitbaseline, 12 weeks

Foot joints and plantar arch motion, ankle range of motion, and maximum ankle extension and flexion during gait

Plantar Ulcers12 months

New cases of foot plantar ulcers

Tactile Sensitivity12 weeks

Evaluation of the tactile sensitivity of four plantar areas with 10g monofilament

Range of Motion12 weeks

Manual goniometry of the range of motion of flexion and extension of the metatarsophalangeal joint of the hallux and ankle.

Risk Classification of Plantar Ulceration12 weeks

Score of the classification of the plantar ulcer risk (IWG diabetic foot)

Foot Health and Functionality12 weeks

Score of the Foot Health Status questionnaire - BRAZIL

Foot Strength12 weeks

Hallux and lesser toes force measured by a pressure plate

Ankle and Knee Joint Moments and Power During Gaitbaseline, 12 weeks

Peak joint moment and eccentric and concentric power by inverse dynamic calculations

Vibration Sensitivity12 weeks

Evaluation of the vibration sensitivity with tuning fork

Neuropathy Symptoms12 weeks

Score of the Michigan Neuropathy Screening Instrument questionnaire Michigan Neuropathy Screening Instrument (MNSI)

EQ-5D Score12 weeks

EQ-5D score of the quality of life of the patient

Trial Locations

Locations (1)

Universidade de São Paulo

🇧🇷

São Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath